Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance
Although anti-tumor activities of type I interferons (IFNs) have been recognized for decades, the molecular mechanisms contributing to clinical response remain poorly understood. The complex functions of these pleiotropic cytokines include stimulation of innate and adaptive immune responses against...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3bdba8d9baec4171a65be46af11a81fb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3bdba8d9baec4171a65be46af11a81fb |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3bdba8d9baec4171a65be46af11a81fb2021-12-02T05:02:12ZMolecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance2372-770510.1016/j.omto.2021.11.006https://doaj.org/article/3bdba8d9baec4171a65be46af11a81fb2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2372770521001558https://doaj.org/toc/2372-7705Although anti-tumor activities of type I interferons (IFNs) have been recognized for decades, the molecular mechanisms contributing to clinical response remain poorly understood. The complex functions of these pleiotropic cytokines include stimulation of innate and adaptive immune responses against tumors as well as direct inhibition of tumor cells. In high-grade, Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer, nadofaragene firadenovec, a non-replicating adenovirus administered locally to express the IFNα2b transgene, embodies a novel approach to deploy the therapeutic activity of type I IFNs while minimizing systemic toxicities. Deciphering which functions of type I IFN are required for clinical activity will bolster efforts to maximize the efficacy of nadofaragene firadenovec and other type I IFN-based therapies, and inform strategies to address resistance. As such, we characterized the phenotypic and molecular response of human bladder cancer cell lines to IFNα delivered in multiple contexts, including adenoviral delivery. We found that constitutive activation of the type I IFN signaling pathway is a biomarker for resistance to both transcriptional response and direct cytotoxic effects of IFNα. We present several genes that discriminate between sensitive and resistant tumor cells, suggesting they should be explored for utility as biomarkers in future clinical trials of type I IFN-based anti-tumor therapies.Jennifer L. GreenRobin E. OsterhoutAmy L. KlovaCarsten MerkwirthScott R.P. McDonnellReza Beheshti ZavarehBryan C. FuchsAdeela KamalJørn S. JakobsenElsevierarticletype I interferonbladder cancerconstitutive ISGIFN resistanceIFN biomarkernadofaragene firadenovecNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENMolecular Therapy: Oncolytics, Vol 23, Iss , Pp 547-559 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
type I interferon bladder cancer constitutive ISG IFN resistance IFN biomarker nadofaragene firadenovec Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
type I interferon bladder cancer constitutive ISG IFN resistance IFN biomarker nadofaragene firadenovec Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Jennifer L. Green Robin E. Osterhout Amy L. Klova Carsten Merkwirth Scott R.P. McDonnell Reza Beheshti Zavareh Bryan C. Fuchs Adeela Kamal Jørn S. Jakobsen Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance |
description |
Although anti-tumor activities of type I interferons (IFNs) have been recognized for decades, the molecular mechanisms contributing to clinical response remain poorly understood. The complex functions of these pleiotropic cytokines include stimulation of innate and adaptive immune responses against tumors as well as direct inhibition of tumor cells. In high-grade, Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer, nadofaragene firadenovec, a non-replicating adenovirus administered locally to express the IFNα2b transgene, embodies a novel approach to deploy the therapeutic activity of type I IFNs while minimizing systemic toxicities. Deciphering which functions of type I IFN are required for clinical activity will bolster efforts to maximize the efficacy of nadofaragene firadenovec and other type I IFN-based therapies, and inform strategies to address resistance. As such, we characterized the phenotypic and molecular response of human bladder cancer cell lines to IFNα delivered in multiple contexts, including adenoviral delivery. We found that constitutive activation of the type I IFN signaling pathway is a biomarker for resistance to both transcriptional response and direct cytotoxic effects of IFNα. We present several genes that discriminate between sensitive and resistant tumor cells, suggesting they should be explored for utility as biomarkers in future clinical trials of type I IFN-based anti-tumor therapies. |
format |
article |
author |
Jennifer L. Green Robin E. Osterhout Amy L. Klova Carsten Merkwirth Scott R.P. McDonnell Reza Beheshti Zavareh Bryan C. Fuchs Adeela Kamal Jørn S. Jakobsen |
author_facet |
Jennifer L. Green Robin E. Osterhout Amy L. Klova Carsten Merkwirth Scott R.P. McDonnell Reza Beheshti Zavareh Bryan C. Fuchs Adeela Kamal Jørn S. Jakobsen |
author_sort |
Jennifer L. Green |
title |
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance |
title_short |
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance |
title_full |
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance |
title_fullStr |
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance |
title_full_unstemmed |
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance |
title_sort |
molecular characterization of type i ifn-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/3bdba8d9baec4171a65be46af11a81fb |
work_keys_str_mv |
AT jenniferlgreen molecularcharacterizationoftypeiifninducedcytotoxicityinbladdercancercellsrevealsbiomarkersofresistance AT robineosterhout molecularcharacterizationoftypeiifninducedcytotoxicityinbladdercancercellsrevealsbiomarkersofresistance AT amylklova molecularcharacterizationoftypeiifninducedcytotoxicityinbladdercancercellsrevealsbiomarkersofresistance AT carstenmerkwirth molecularcharacterizationoftypeiifninducedcytotoxicityinbladdercancercellsrevealsbiomarkersofresistance AT scottrpmcdonnell molecularcharacterizationoftypeiifninducedcytotoxicityinbladdercancercellsrevealsbiomarkersofresistance AT rezabeheshtizavareh molecularcharacterizationoftypeiifninducedcytotoxicityinbladdercancercellsrevealsbiomarkersofresistance AT bryancfuchs molecularcharacterizationoftypeiifninducedcytotoxicityinbladdercancercellsrevealsbiomarkersofresistance AT adeelakamal molecularcharacterizationoftypeiifninducedcytotoxicityinbladdercancercellsrevealsbiomarkersofresistance AT jørnsjakobsen molecularcharacterizationoftypeiifninducedcytotoxicityinbladdercancercellsrevealsbiomarkersofresistance |
_version_ |
1718400761460686848 |